KR810000291B1 - Process for preparing of 3,4-dihydro-2-methyl-4-oxo-2h-1,2-benzothiazine-3-carboxylic acid-1,1-dioxide - Google Patents

Process for preparing of 3,4-dihydro-2-methyl-4-oxo-2h-1,2-benzothiazine-3-carboxylic acid-1,1-dioxide Download PDF

Info

Publication number
KR810000291B1
KR810000291B1 KR7902985A KR790002985A KR810000291B1 KR 810000291 B1 KR810000291 B1 KR 810000291B1 KR 7902985 A KR7902985 A KR 7902985A KR 790002985 A KR790002985 A KR 790002985A KR 810000291 B1 KR810000291 B1 KR 810000291B1
Authority
KR
South Korea
Prior art keywords
benzothiazine
dihydro
methyl
oxo
dioxide
Prior art date
Application number
KR7902985A
Other languages
Korean (ko)
Inventor
디이트릿히 함멘 필맆
Original Assignee
테렌스 제이 가라게에
화이자 인코포레이팃드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 테렌스 제이 가라게에, 화이자 인코포레이팃드 filed Critical 테렌스 제이 가라게에
Priority to KR7902985A priority Critical patent/KR810000291B1/en
Application granted granted Critical
Publication of KR810000291B1 publication Critical patent/KR810000291B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/101,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/141,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/161,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/021,2-Thiazines; Hydrogenated 1,2-thiazines

Abstract

Title compd. (I; R2 = 2-pyridyl or 2-thiazolyl), useful as antiinflammatory agent, was prepd. by coupling R2NH2 and compd. II(Z = Cl, Br or OX; X = H, C1-4 alkoxycarbonyloxy or benzyloxycarbonyloxy). Thus, 5.0 g methyl-4,3-dihydro-2-methyl-4-oxo-2H-1,2-benzothiazine-3-carboxylate-1,1-dioxide was added in aq. soln. of sodium hydroxide at 70≰C, and obtained slurry was heated at 90-95≰C for 45 min to give I.

Description

3,4-디하이드로-2-메틸-4-옥소-2H-1,2-벤조티아진-3-카복실산-1,1-디옥사이드의 제조방법Method for preparing 3,4-dihydro-2-methyl-4-oxo-2H-1,2-benzothiazine-3-carboxylic acid-1,1-dioxide

본 발명은 비스테로이드성 소염제로서 가치있는 중간체인 3,4-디하이드로-2-메틸-4-옥소-2H-1,2-벤조티아진-3-카복실산-1,1-디옥사이드의 제조방법에 관한 것이다.The present invention relates to a process for preparing 3,4-dihydro-2-methyl-4-oxo-2H-1,2-benzothiazine-3-carboxylic acid-1,1-dioxide, which is a valuable intermediate as a nonsteroidal anti-inflammatory agent. It is about.

좀더 특히 본 발명은 3,4-디하이드로-2-메틸-4-옥소-2H-1,2-벤조티아진-3-카복실산-1,1-디옥사이드의 알킬 또는 아랄길 에스테르로 염기 가수분해하여 상기 카복실산 화합물을 제조하는 것과 이산을 소염제인 N-(2-피리딜)-3,4-디하이드로-2-메틸-4-옥소-2H-1,2-벤조티아진-3-카복사미드-1,1-디옥사이드와 N-(2-티아졸릴)-3,4-디하이드로-2-메틸-4-옥소-2H-1,2-벤조티아진-3-카복사미드-1,1-디옥사이드를 제조하는데 사용하는 것에 관한 것이다.More particularly, the present invention can be obtained by base hydrolysis with alkyl or aralkyl esters of 3,4-dihydro-2-methyl-4-oxo-2H-1,2-benzothiazine-3-carboxylic acid-1,1-dioxide. Preparation of the carboxylic acid compound and N- (2-pyridyl) -3,4-dihydro-2-methyl-4-oxo-2H-1,2-benzothiazine-3-carboxamide which dissolves diacids -1,1-dioxide and N- (2-thiazolyl) -3,4-dihydro-2-methyl-4-oxo-2H-1,2-benzothiazine-3-carboxamide-1,1 It relates to the use to prepare dioxide.

β-케토카복실산의 불안전성은, 그들이 탈카복실화 되기 쉽다는 것에 의해 입증되며, 이 기술분야에 숙련된 자에겐 기지의 사실이다.The instability of β-ketocarboxylic acids is evidenced by their ease of decarboxylation, and is known to those skilled in the art.

3,4-디하이드로-4-옥소-2H-1,2-벤조티아진-3-카복실산-1,1-디옥산류가 상응하는 에스테르의 가수분해에 의해 제조되나 이들이 일단 생성된 후 급속히 탈카복실화 된다는 것은 공지의 사실이다.3,4-Dihydro-4-oxo-2H-1,2-benzothiazine-3-carboxylic acid-1,1-dioxanes are prepared by hydrolysis of the corresponding esters but are rapidly dehydrated once they have been produced It is known to be carboxylated.

이 불안정성은 그들의 β-케토구조에 의한 것이라는 것이 관찰되엇다.It was observed that this instability is due to their β-keto structure.

소염제로서 유용한 N-치환-3,4-디하이드로-4-옥소-2H-1,2-벤조티아진-3-카복사미드-1,1-디옥사이드류의 제법은 공지되어 있다. N-치환-벤조티아진-카복사미드-1,1-디옥사이드류의 두가지 합성경로 ; 즉 (a) 적당한 3,4-디하이드로-4-옥소-2H-1,2-벤조티아진-1,1-디옥사이드류를 유기 이소시아네이트와 반응시키는 경로와 (b) 3,4-디하이드로-4-옥소-2H-1,2-벤조티아진-3-카복실산-1,1-디옥사이드의 에스테르를 암모니아 또는 적당한 아민으로 가암모니아 분해시키는 경로가 공지되어 있다. 또한 아미노기 전달 반응에 의해 N-치환기가 복소환식 성분인 화합물을 제조하는 방법도 공지되어 있다. 3,4-디하이드로-4-알콕시-2H-1,2-벤조티아진-3-카복실산-1,1-디옥사이드를 커플링 조촉매(助觸媒)(디사이클로헥실 카보디미드, pocl3, N-에톡시카보닐-2-에시-1,2-디하이드로 퀴놀린)와 접촉시킨 후 생성된 카복사미드를 광산과 접촉시켜 4-알콕시기를 4-옥소로 전환시킴으로써 카복사미드 유도체를 제조하는 방법이 보고되어 있다.The production of N-substituted-3,4-dihydro-4-oxo-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxides useful as anti-inflammatory agents is known. Two synthetic routes of N-substituted-benzothiazine-carboxamide-1,1-dioxides; That is, (a) a route for reacting a suitable 3,4-dihydro-4-oxo-2H-1,2-benzothiazine-1,1-dioxide with an organic isocyanate and (b) 3,4-dihydro- Routes for ammonolysis of esters of 4-oxo-2H-1,2-benzothiazine-3-carboxylic acid-1,1-dioxide with ammonia or suitable amines are known. Also known are methods for producing compounds wherein the N-substituent is a heterocyclic component by amino group transfer reactions. 3,4-dihydro-4-alkoxy-2H-1,2-benzothiazine-3-carboxylic acid-1,1-dioxide with coupling promoter (dicyclohexyl carbodimide, pocl 3 , N-ethoxycarbonyl-2-esci-1,2-dihydro quinoline), followed by contacting the resulting carboxamide with a photoacid to convert the 4-alkoxy group to 4-oxo to prepare a carboxamide derivative. How to do is reported.

각 예마다 이제까지 보고된 이런 산의 β-케토 광능의 불안정성을 막기 위해서는 일시적인 중간체로서조차도 3,4-디하이드로-4-옥소-2H-1,2-벤조티아진-3-카복실산-1,1-디옥사이드의 생성을 피하도록 특수한 합성경로를 적용해야 한다.In each case, 3,4-dihydro-4-oxo-2H-1,2-benzothiazine-3-carboxylic acid-1,1, even as a temporary intermediate, was used to prevent the instability of the β-keto photosensitivity of these acids so far reported. Special synthetic routes should be applied to avoid the formation of dioxide.

이런 산의 불안정성은 β-케토산이 탈카복실화 되기 쉽다는 것과 일치된다.This acid instability is consistent with β-keto acid being prone to decarboxylation.

이제금 3,4-디하이드로-2-메틸-4-옥소-2H-1,2-벤조티아진-3-카복실산-1,1-디옥사이드(구조식 I)기 수산화 이온 공급원 존재하에 그의 에스테르를 가수 분해시키고 이어 반응혼합물을 pH 6.0 이하로 산성화 함으로써 대기압 하에 안정한 결정성 물질로서 제조되고, 달리될 수 있다는 것이 놀라웁게도 밝혀졌다.The ester of 3,4-dihydro-2-methyl-4-oxo-2H-1,2-benzothiazine-3-carboxylic acid-1,1-dioxide (formula I) is present in the presence of a source of hydroxide ions. It has been surprisingly found that it can be prepared as a stable crystalline material under atmospheric pressure by decomposing and then acidifying the reaction mixture to pH 6.0 or below, and can be otherwise.

Figure kpo00001
Figure kpo00001

이렇게 생성된 적당한 아민의 아실화에 의해 하기 구조식 II와 같은 비-스테로이드성 소염제를 제조하는데 가치있는 중간체이다.By acylation of the appropriate amines thus produced are valuable intermediates for the preparation of non-steroidal anti-inflammatory agents such as formula II.

Figure kpo00002
Figure kpo00002

구조식 II에서 Z은 2-피리딜 및 2-티아졸릴로 구성된 기로부터 선택된다.Z in formula II is selected from the group consisting of 2-pyridyl and 2-thiazolyl.

3,4-디하이드로-2-메틸-4-옥소-2H-1,2-벤조티아진-3-카복실산-1,1-디옥사이드(I)를 제조하는 본 발명의 방법은 하기 구조식 III의 화합물을 수산 이온 공급원 존재하에 가수분해시키고 이어 반응혼합물을 산성화하여 구조식 I의 화합물을 얻는 것으로 이루어진다.The process of the present invention for preparing 3,4-dihydro-2-methyl-4-oxo-2H-1,2-benzothiazine-3-carboxylic acid-1,1-dioxide (I) is a compound of formula Is hydrolyzed in the presence of a source of hydroxyl ions and then acidified to give a compound of formula I.

Figure kpo00003
Figure kpo00003

구조식 I, II 및 III의 화합물은 케토 및 에놀 호변이성체의 혼합물로서 존재한다.Compounds of structures I, II and III exist as a mixture of keto and enol tautomers.

구조식 I, II 및 III은 케토 호변이성체를 나타낸 것이다. 여기 서술한 화합물의 호변이성체 둘다가 본 발명의 범위내에 포함된다.Formulas I, II, and III represent keto tautomers. Both tautomers of the compounds described herein are included within the scope of the present invention.

편리하게 케토형만을 예시화 하였다.Conveniently, only keto forms are illustrated.

3,4-디하이드로-2-메틸-4-옥소-2H-1,2-벤조티아진-3-카복실산-1,1-디옥사이드 에스테르의 제조방법이 공지되어 있다.Methods for preparing 3,4-dihydro-2-methyl-4-oxo-2H-1,2-benzothiazine-3-carboxylic acid-1,1-dioxide ester are known.

C1-C4의 알킬 에스테르 특히 메틸 및 에틸에스테르는 그들이 제조하기 용이하므로, 가수분해 공정시 반응체로서 유리하다.Alkyl esters of C 1 -C 4 , in particular methyl and ethyl esters, are easy to prepare and are therefore advantageous as reactants in hydrolysis processes.

구조식 III 에스테르의 가수분해는 수산 이온 공급원으로써 예컨대 알칼리 금속 수산화물 및 알칼리 토금속 수산화물을 사용하는 수산이온 존재하에 수행한다. 가수분해는 수성 또는 비수성 용매계내에서 수행될수 있다. 수용매계내에서 수행될 때 가수분해는 20℃부터 반응매질의 환류온도까지 사이에서 수행된다. 금속 수산화물중에서는 알칼리금속 수산화물이 알칼리토금속 수산화물보다 수용성이 더 크므로 더 바람직하며 유리하다. 바람직한 알칼리금속 수산화물은 …나트륨 및 칼륨 수산화물로서 그들의 유용성 및 대규모 생산시 그들이 딴 알칼리 금속 수산화물보다 더 경제적으로 유리하기 때문에 바람직하다.Hydrolysis of the structural formula III esters is carried out in the presence of hydroxide ions using, for example, alkali metal hydroxides and alkaline earth metal hydroxides as source of hydroxyl ions. Hydrolysis can be carried out in an aqueous or non-aqueous solvent system. When performed in the aqueous medium, the hydrolysis is carried out between 20 ° C. and the reflux temperature of the reaction medium. Among metal hydroxides, alkali metal hydroxides are more preferred and advantageous because they are more water soluble than alkaline earth metal hydroxides. Preferred alkali metal hydroxides are It is preferred because of their utility as sodium and potassium hydroxides and when they are more economically advantageous than other alkali metal hydroxides in large scale production.

바람직한 알칼리토금속 수산화물은 칼슘과 마그네슘 수산화물로서 이들이 딴 알칼리토금속 수산화물보다 가격이 유용성면에서 더 유리하기 때문이다.Preferred alkaline earth metal hydroxides are calcium and magnesium hydroxides because they are more advantageous in price than their alkaline earth metal hydroxides.

금속 수산화물 외에도, 예컨대 테트라알킬 암모늄 하이드록사이드, 트리알킬 벤질암모늄 하이드록사이드 및 디알킬 디벤질 암모늄하이드록사이드(여기서 알킬기는 C1-C12이다)와 같은 4급 수산화암모늄도 수산이온 공급원으로 사용될 수 있다. 이런 염기에 대표적인 것으로는 테트라메틸 암모늄 하이드록사이드, 디메틸 디벤질 암모늄 하이드록사이드 및 트리메틸벤질 암모늄 하이드록사이드가 있다.In addition to metal hydroxides, quaternary ammonium hydroxides such as, for example, tetraalkyl ammonium hydroxide, trialkyl benzyl ammonium hydroxide and dialkyl dibenzyl ammonium hydroxide, where the alkyl group is C 1 -C 12, are also sources of hydroxide ion. Can be used. Representative of such bases are tetramethyl ammonium hydroxide, dimethyl dibenzyl ammonium hydroxide and trimethylbenzyl ammonium hydroxide.

에스테르 반응체에 대한 금속수산화물의 몰비는 임계적인 것은 아니다.The molar ratio of metal hydroxide to ester reactant is not critical.

약 1:1-10:1로 달라진다. 실시에 있어, 약 1:1-5:1 몰비가 가수 분해의 만족할만한 속도와 수율을 얻는데 효과적이라는 것이 발견되었다.About 1: 1-10: 1. In practice, it has been found that about 1: 1-5: 1 molar ratios are effective in obtaining satisfactory rates and yields of hydrolysis.

비-수성 용매계에서 수행할 경우, 상기 열거된 것과 동일한 금속 수산화물이 수산이온 공급원으로 사용될 수 있다.When performed in a non-aqueous solvent system, the same metal hydroxides as listed above can be used as the source of hydroxide ions.

효율적으로 반응을 수행하기 위해, 예컨대 마크로사이클릭 에테르와 같은 크라운 에테르의 존재에 의해 벤젠 또는 톨루엔과 같은 탄화수소 용매중의 금속 수산화물에서 얻어진 용해 효과를 이용한다.In order to carry out the reaction efficiently, the dissolution effect obtained in the metal hydroxide in a hydrocarbon solvent such as benzene or toluene is used, for example, by the presence of a crown ether such as macrocyclic ether.

본 방법에 유용한 크라운 에테르의 대표적인 것은 18-크라운-6, 디벤조-18-크라운-6, 사이클로헥실-18-크라운-6, 디사이클로헥실-15-크라운-6, 및 사이클로헥실-15-크라운-5이다.Representative crown ethers useful in the process include 18-crown-6, dibenzo-18-crown-6, cyclohexyl-18-crown-6, dicyclohexyl-15-crown-6, and cyclohexyl-15-crown -5.

비-수성용매계에서 유용한 수산 이온 공급원은 알칼리금속 수산화물로서, 크라운 에테르가 알칼리금속 양이온과 착화합물을 형성하려는 경향이 비교적 강하며, 그들이 용해가 잘 되며, 크라운 에테르 존재하에 반응성이 상승되기 때문이다.Useful sources of hydroxyl ions in non-aqueous solvent systems are alkali metal hydroxides, since crown ethers have a relatively strong tendency to form complexes with alkali metal cations, because they dissolve well and increase their reactivity in the presence of crown ethers.

바람직한 알칼리금속 수산화물은 수산화칼륨 및 나트륨이다.Preferred alkali metal hydroxides are potassium hydroxide and sodium.

크라운 에테르 보조하에 비-수성계에서의 가수분해법은 소망의 3,4-디하이드로-2-메틸-4-옥소-2H-1,2-벤조티아진-3-카복실산-1,1-디옥사이드가 실질적인 수율로 얻어지므로 바람직한 가수분해법이다.Hydrolysis in a non-aqueous system with crown ether assistance results in the desired 3,4-dihydro-2-methyl-4-oxo-2H-1,2-benzothiazine-3-carboxylic acid-1,1-dioxide. Since it is obtained in substantial yield, it is a preferable hydrolysis method.

일반적으로 크라운 에테르를 사용할 경우, 크라운 에테르 및 에스테르 반응체에 대한 알칼리금속 또는 알칼리토금속 수산화물의 몰비는 1:0.1-100:1:10으로 달라진다. 실지로 실시하는데 있어서는 과량의 금속수산화물이 사용되는데 왜냐하면 반응시간을 최소로 해주며 적은 용량을 사용했을때 보다 좀더 완전하게 에스테르를 가수분해 시키기 때문이다. 물론 좀더 많은 비율의 크라운 에테르가 사용될 수 있다. 반응은 보통 사용된 용매의 환류온도에서 수행된다. 일반적으로 온도는 약 80-150℃ 범위로서 물론 사용된 용매(예 : 벤젠, 톨루엔, 크실렌)에 따라 달라지게 된다.In general, when crown ethers are used, the molar ratio of alkali metal or alkaline earth metal hydroxides to crown ethers and ester reactants varies from 1: 0.1-100: 1: 10. In practice, excess metal hydroxide is used because it minimizes the reaction time and hydrolyzes the ester more completely than when using a small volume. Of course, higher proportions of crown ethers may be used. The reaction is usually carried out at the reflux temperature of the solvent used. Generally, the temperature is in the range of about 80-150 ° C. and of course depends on the solvent used (eg benzene, toluene, xylene).

크라운 에테르-알칼리금속 착 화합물은 미리 생성되거나 또는 원위치에서 생성될 수 있다. 조작을 간편히 하기 위해서는 착화합물을 원위치에서 생성하고, 반응을 가속시키기 위해 과량의 알칼리금속 수산화물을 사용하는 것이 유리하다.Crown ether-alkalimetal complex compounds may be produced in advance or in situ. To simplify the operation it is advantageous to produce the complex in situ and to use an excess of alkali metal hydroxide to accelerate the reaction.

착화합물은 예컨대 수산화칼륨과 같은 적당한 염기와 적당한 크라운 에테르를 메탄올 또는 벤젠중에서 반응시켜서 제조한다. 메탄올 또는 벤젠을 제거하고 이에 톨루엔 또는 벤젠을 잔류물에 가한다. 가수분해 생성물은 가수분해 생성물의 수용액을 pH 0-6.0으로 조절함으로써 회수된다. 광산 및 특히 염산이 경제적인 이유 때문에 일반적으로 사용된다. 물론 가수분해를 비-수성 용매계내에서 수행할 경우 고체 가수분해 생성물을 적당한 방법(여과, 원심분리)를 사용하여 용매계로부터 분리시킨 후 물에 용해하고 pH를 조절한다. 유리한 pH 범위는 약 1-4이며 ; 바람직한 범위는 pH 2-3이다.Complexes are prepared by reacting a suitable base such as, for example, potassium hydroxide with a suitable crown ether in methanol or benzene. Methanol or benzene is removed and toluene or benzene is added to the residue. The hydrolysis product is recovered by adjusting the aqueous solution of the hydrolysis product to pH 0-6.0. Mines and especially hydrochloric acid are commonly used for economic reasons. Of course, if the hydrolysis is carried out in a non-aqueous solvent system, the solid hydrolysis product is separated from the solvent system using a suitable method (filtration, centrifugation), then dissolved in water and the pH adjusted. Advantageous pH ranges are about 1-4; The preferred range is pH 2-3.

상기 서술한 바와 같이, 3,4-디하이드로-2-메틸-4-옥소-2H-1,2-벤조티아진-3-카복실산-1,1-디옥사이드는 효과적인 소염제인 N-(2-피리딜)- 및 N-(2-티아졸릴)-3,4-디하이드로-2-메틸-4-옥소-2H-1,2-벤조티아진-3-카복사미드-1,1-디옥사이드의 제조에 가치있는 중간체이다.As mentioned above, 3,4-dihydro-2-methyl-4-oxo-2H-1,2-benzothiazine-3-carboxylic acid-1,1-dioxide is an effective anti-inflammatory agent N- (2-pyridine). Di)) and N- (2-thiazolyl) -3,4-dihydro-2-methyl-4-oxo-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide It is a valuable intermediate for manufacturing.

이들 화합물은 적당한 아민(R2NH2) 예컨대, 2-아미노피리딘 또는 2-아미노티아졸을 3,4-디사이드로-2-메틸-4-옥소-2H-1,2-벤조티아진-3-카복실산-1,1-디옥사이드의 카복시기의 반응성 관능 유도체로 아실화시켜 제조한다. 산 반응체의 적당한 반응성 관능 유도체는 산클로라이드, 산브로마이드, 산아지드 및 N-하이드록시 석시니미드, N-하이드록시프탈리미드, 페놀 또는 티오페놀과의 활성 에스테르 또는 티오에스테르 예컨대 N,N'-디사이클로 헥실카보디미드, N,N'-카보닐디이미다졸, N,N'-카보닐-디트리아졸, N-에톡시카보닐-2-에톡시-1,2-디하이드로퀴놀린과 같은 각종 탈수 "커플링" 시약과의 반응성 중간체 및 알콕시 카본산(특히 알콕시기가 C1-C4인 것) 또는 벤질옥시 카본산과의 혼합무수물이다.These compounds may be selected from suitable amines (R 2 NH 2 ) such as 2-aminopyridine or 2-aminothiazole with 3,4-diside-2-methyl-4-oxo-2H-1,2-benzothiazine- Prepared by acylating with a reactive functional derivative of the carboxy group of 3-carboxylic acid-1,1-dioxide. Suitable reactive functional derivatives of acid reactants are acid chlorides, acid bromide, acid azide and active esters or thioesters with N-hydroxy succinimide, N-hydroxyphthalimide, phenol or thiophenol such as N, N ' Dicyclohexylcarbodimid, N, N'-carbonyldiimidazole, N, N'-carbonyl-ditriazole, N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline Reactive intermediates with various such dehydrating coupling agents and alkoxy carboxylic acids (particularly alkoxy groups having C 1 -C 4 ) or mixed anhydrides with benzyloxy carboxylic acids.

바람직한 아실화제는 제조의 용이성 때문에 산클로라이드와 혼합 무수물이다.Preferred acylating agents are mixed anhydrides with acid chlorides because of their ease of preparation.

아실화는 수성 또는 비-수성 용매계 중에서 수행된다. 수성계에서, 반응은 일반적으로 pH 6-9, 온도 약 0°-50℃ 사이에서 수행된다. 산클로라이드를 사용할 경우, 반응은 메틸 이소부틸케톤 및 저급알킬 아세테이트와 같은 물 혼화성 유기용매와 물과의 불안정한 유탁액 중에서 pH 2-4에서 수행될 수 있다. 수성계에서 카보디미드를 사용할경우 pH를 약 5-8로 조절하는 것이 유리하며, pH 6-7인 것이 바람직하다.Acylation is performed in an aqueous or non-aqueous solvent system. In an aqueous system, the reaction is generally carried out at pH 6-9, at a temperature of about 0 ° -50 ° C. When using acid chlorides, the reaction can be carried out at pH 2-4 in an unstable emulsion of water miscible organic solvents such as methyl isobutyl ketone and lower alkyl acetates and water. When using carbodimid in an aqueous system it is advantageous to adjust the pH to about 5-8, preferably at pH 6-7.

전형적인 방법으로, 산 반응체 및 카보디미드를 동 비율로 적당한 용매(테트라하이드로푸란, 디옥산)중에서 혼합하고, 아민을 함유한 물-물혼화성 유기용매 용액(물과 디옥산 또는 테트라하이드로푸란)을 실온에서 가한 후 이 혼합물을 반응이 완결될 때까지 수시간 동안 교반한다. 일반적으로 -5°-30℃의 온도가 사용된다. 대부분의 예에서 약 10% 이상 과량의 축합제가 사용된다. 아실화 생성물은 기지의 방법에 의해 회수된다.In a typical manner, acid reactants and carbodimids are mixed in the same proportions in a suitable solvent (tetrahydrofuran, dioxane), and a water-water miscible organic solvent solution containing amine (water and dioxane or tetrahydrofuran) After addition at room temperature the mixture is stirred for several hours until the reaction is complete. Generally a temperature of -5 ° -30 ° C is used. In most instances an excess of about 10% condensation agent is used. Acylation products are recovered by known methods.

아실화제로 산클로라이드를 사용하는 경우, 산소용체로서 바람직하게는 트리에틸아민, 피리딘, N-메틸아닐린, 또는 과량의 아민반응체(R2NH2)와 같은 유기염기나 또는 탄산나트륨이나 중탄산나트륨과 같은 무기염기를 사용한다.In the case of using an acid chloride as the acylating agent, the oxygen solution is preferably an organic base such as triethylamine, pyridine, N-methylaniline, or an excess amine reactant (R 2 NH 2 ), or sodium carbonate or sodium bicarbonate. Use the same inorganic base.

[실시예 1]Example 1

3,4-디하이드로-2-메틸-4-옥소-2H-1,2-벤조티아진-3-카복실산-1,1-디옥사이드(수성매질중에서 가수분해)3,4-dihydro-2-methyl-4-oxo-2H-1,2-benzothiazine-3-carboxylic acid-1,1-dioxide (hydrolysis in aqueous medium)

메틸 4,3-디하이드로-2-메틸-4-옥소-2H-1,2-벤조티아진-3-카복실레이트-1,1-디옥사이드(5.0g)를 수산화나트륨(160g)의 수(500ml) 용액에 70℃에서 가한다. 생성된 담황색 슬러리를 90˚-95℃에서 45분간 가열한 후 빙수욕중에서 실온으로 냉각한다. 반응혼합물의 pH를 농염산(350ml)을 서서히 첨가하여 1-1,5로 조절한다.Methyl 4,3-dihydro-2-methyl-4-oxo-2H-1,2-benzothiazine-3-carboxylate-1,1-dioxide (5.0 g) in sodium hydroxide (160 g) (500 ml) ) Is added to the solution at 70 ℃. The resulting pale yellow slurry is heated at 90 ° -95 ° C. for 45 minutes and then cooled to room temperature in an ice water bath. The pH of the reaction mixture is adjusted to 1-1,5 by slowly adding concentrated hydrochloric acid (350ml).

필요에 따라 온도를 35℃ 이하로 유지시키기 위해 얼음 조각을 가한다. 산 생성물이 침전되며, 10°-15℃에서 15분간 교반하여 과립화시킨다. 흡입 여과하여 회수하고 물(100ml)로 세척한 후 물(250ml)에 30분간 재슬러리를 하여 과량의 염산을 제거한다.If necessary, add ice cubes to keep the temperature below 35 ° C. The acid product is precipitated and granulated by stirring at 10 ° -15 ° C. for 15 minutes. The resultant was collected by suction filtration, washed with water (100 ml) and then reslurried in water (250 ml) for 30 minutes to remove excess hydrochloric acid.

다시 흡입 여과한 후 물(100ml)로 세척한다. 습윤 여과 케이크 25g(총습윤 여과물은 25.5g이다)을 가온한 메탄올에 용해시키고 용액을 여과한 후 물(50ml)을 여액에 가한다. 종결정을 첨가하면 생성물이 즉시 침전된다. 슬러리를 약 10℃에서 30분간 교반하여 과립화 한다. 흰색 결정성 생성물을 여과하여 분리하고 물로 세척한 후 공기 건조한다. 수득량 =13.2g, 융점 144°-146℃After suction suction filtration again and washed with water (100ml). 25 g of wet filter cake (total wet filtrate is 25.5 g) are dissolved in warm methanol, the solution is filtered and water (50 ml) is added to the filtrate. The addition of seed crystals immediately precipitates the product. The slurry is granulated by stirring at about 10 ° C. for 30 minutes. The white crystalline product is isolated by filtration, washed with water and air dried. Yield = 13.2 g, Melting point 144 ° -146 ° C

여액을 1/2용량으로 증발시켜 생성물(3.2g)을 더 얻는다. 이 과정을 반복하여 3차 결정을 회수한다(2.6g). 총 수득량=16.4g(34.6%) MS(분자이온)=255The filtrate is evaporated to 1/2 volume to yield more product (3.2 g). This process is repeated to recover the tertiary crystals (2.6 g). Total yield = 16.4 g (34.6%) MS (molecular ion) = 255

IR(KBr) : 3535cm-1(에놀성 OH), 2900-2000cm-1 IR (KBr): 3535cm -1 (Enol OH), 2900-2000cm -1

(산 OH), 1660cm-1(C=O), 1340, 1170cm-1(SO2).(Acid OH), 1660 cm −1 (C═O), 1340, 1170 cm −1 (SO 2 ).

염기로서 수산화칼륨, 수산화리듐, 수산화칼슘, 수산화마그네슘 또는 수산화바륨을 사용하여 상기 방법을 반복하여 유사한 결과를 얻는다.Similar results are obtained by repeating the above method using potassium hydroxide, lithium hydroxide, calcium hydroxide, magnesium hydroxide or barium hydroxide as the base.

[실시예 2]Example 2

3,4-디하이드로-2-메틸-4-옥소-2H-1,2-벤조티아진-3-카복실산-1,1-디옥사이드 비수성매질중에서의 가수분해(크라운 에테르법)Hydrolysis in 3,4-dihydro-2-methyl-4-oxo-2H-1,2-benzothiazine-3-carboxylic acid-1,1-dioxide nonaqueous medium (crown ether method)

수산화나트륨(2.8g), 메틸 3,4-디하이드로-2-메틸-4-옥소-2H-1,2-벤조티아진-3-카복실레이트-1,1-디옥사이드(6.73g) 및 벤젠(100ml)의 혼합물을 교반하고 여기에 디사이클로헥실-18-크라운-6-에테르(0.93g)의 벤젠(10ml) 용액을 1분에 걸쳐 가한다. 반응혼합물을 환류하에 2시간 동안 가열한다. 수산화 칼륨(2.8g)을 더 가하고 환류를 총 50시간 계속한다. 황갈색 슬러리를 뜨거울때 여과하고 여과케이크를 벤젠(50ml)으로 세척한 후 건조한다. 이것을 물(100ml)에 용해시킨 후 온도를 약 15℃로 유지하면서 염산으로 용액의 pH를 1.0으로 조절한다. 생성된 침전을 30분간 과립화하고 여과한 후 물로 세척하고 건조한다(조 생성물 4.4g). 조 생성물을 가온한 메탄올(49ml)에 용해하고, 용액을 여과한 후 물(63ml)을 천천히 첨가하여 희석한다. 생성된 침전을 10-15℃에서 30분간 과립화한 후 여과하고 물(2×10ml)로 세척하고 공기 건조시킨다. 수득량=3.5g 61.9% 융점 134-141℃Sodium hydroxide (2.8 g), methyl 3,4-dihydro-2-methyl-4-oxo-2H-1,2-benzothiazine-3-carboxylate-1,1-dioxide (6.73 g) and benzene ( 100 ml) is stirred and to this is added a solution of benzene (10 ml) of dicyclohexyl-18-crown-6-ether (0.93 g) over 1 minute. The reaction mixture is heated at reflux for 2 hours. Add potassium hydroxide (2.8 g) and continue refluxing for a total of 50 hours. The tan slurry is filtered when hot and the filter cake is washed with benzene (50 ml) and dried. After dissolving this in water (100 ml), the pH of the solution was adjusted to 1.0 with hydrochloric acid while maintaining the temperature at about 15 ° C. The resulting precipitate is granulated for 30 minutes, filtered, washed with water and dried (4.4 g of crude product). The crude product is dissolved in warm methanol (49 ml), the solution is filtered and diluted by the slow addition of water (63 ml). The resulting precipitate is granulated at 10-15 ° C. for 30 minutes, then filtered, washed with water (2 × 10 ml) and air dried. Yield = 3.5g 61.9% Melting Point 134-141 ° C

18-크라운-6, 디벤조-18-크라운-6, 사이클로헥실-18-크라운-6, 사이클로헥실-15-크라운-5-과 수산화나트륨 또는 칼륨, 수산화리튬과 디벤조-14-크라운 4 : 수산화바륨 또는 스트론툼과 미나프탈-20-크라운-618-crown-6, dibenzo-18-crown-6, cyclohexyl-18-crown-6, cyclohexyl-15-crown-5- and sodium hydroxide or potassium, lithium hydroxide and dibenzo-14-crown 4: Barium hydroxide or strontum and Minaphthal-20-crown-6

또는 수산화칼륨과 디 벤조-30-크라운-10을 사용하고 상기 방법을 반복하여 산을 얻는다.Or using potassium hydroxide and dibenzo-30-crown-10 and repeating the above procedure to obtain the acid.

[실시예 3]Example 3

실시예 1 또는 2의 방법에 따라 하기 표에 에스테르를 3,4-디하이드로-2-메틸-4-옥소-2H-1,2-벤조티아진-3-카복실산-1,1-디옥사이드로 가수분해시킨다.According to the method of Example 1 or 2, the esters in the following table are synthesized with 3,4-dihydro-2-methyl-4-oxo-2H-1,2-benzothiazine-3-carboxylic acid-1,1-dioxide. Decompose

Figure kpo00004
Figure kpo00004

[실시예 4]Example 4

N-(2-피리딜)-3,4-디하이드로-2-메틸-4-옥소-2H-1,2-벤조티아진-3-카복사미드-1,1-디옥사이드N- (2-pyridyl) -3,4-dihydro-2-methyl-4-oxo-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide

자기교반기, 환류냉각기 및 초자마개를 갖춘 25ml용 3겹 둥근바닥 플라스크에 티오닐 클로라이드(1.82ml), 이소프로필에테르(12.8ml) 및 3,4-디하이드로-2-메틸-4-옥소-2H-1,2-벤조티아진-3-카복실산-1,1-디옥사이드(1.28g)를 넣는다. 혼합물을 환류하에 가열하고 5시간 교반한 후 감압하에 증발시킨다. 잔사를 N,N-디메틸포름아미드(10ml)에 용해하여 생성된 용액을 직접 다음 과정에 사용한다.25 ml three-ply round-bottomed flask with magnetic stirrer, reflux condenser and choker stopper, thionyl chloride (1.82 ml), isopropyl ether (12.8 ml) and 3,4-dihydro-2-methyl-4-oxo-2H -1,2-benzothiazine-3-carboxylic acid-1,1-dioxide (1.28 g) is added. The mixture is heated to reflux, stirred for 5 hours and then evaporated under reduced pressure. The residue was dissolved in N, N-dimethylformamide (10 ml) and the resulting solution was used directly in the next step.

상기 생성된 산클로라이드 N,N-디메틸포름아미드 용액에 교반하면서 2-아미노피리딘(1.03g)을 가한다. 발열 반응이 일어나며 적색이 전개되면서 약 5분 내에 등황색으로 변한다. 반응 혼합물을 하룻밤 교반한 후 물(40ml)을 천천히 가하여 희석시킨다. 생성된 침전을 30분간 과립화하고 여과한 후 물로 세척하고 공기 건조한다(1.3g., 79%). 융점 160-175℃.To the resulting acid chloride N, N-dimethylformamide solution was added 2-aminopyridine (1.03 g) while stirring. An exothermic reaction occurs and red develops to orange in about 5 minutes. The reaction mixture is stirred overnight and then diluted by the slow addition of water (40 ml). The resulting precipitate is granulated for 30 minutes, filtered, washed with water and air dried (1.3 g., 79%). Melting point 160-175 ° C.

이것을 50°-60℃에서 N,N-디메틸아세트아미드(0.1g당 1ml)에 용해하고, 생성된 침전에 5배 용량의 메탄올을 가하고 냉각하여 정제한다. 순수 생성물의 수율=30% 융점 198-200℃It is dissolved in N, N-dimethylacetamide (1 ml per 0.1 g) at 50 ° -60 ° C. and purified by adding 5 times the volume of methanol to the resulting precipitate. Yield of pure product = 30% Melting point 198-200 ° C

화합물은 적외선 및 질량분광 분석법으로 확인한다.Compounds are identified by infrared and mass spectrometry.

티오닐 브로마이드를 티오닐클로라이드 대신 사용해도 유사한 결과가 얻어진다.Similar results are obtained when thionyl bromide is used in place of thionylchloride.

[실시예 5]Example 5

N-(2-티아졸릴)-3,4-디하이드로-2-메틸-4-옥소-2H-1,2-벤조티아진-3-카복사미드-1,1-디옥사이드N- (2-thiazolyl) -3,4-dihydro-2-methyl-4-oxo-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide

3,4-디하이드로-2-메틸-4-옥소-2H-1,2-벤조티아진-3-카복실산-1,1-디옥사이드 510mg, 티오닐클로라이드 1.45ml, 이소프로필에테르 10.0ml, 및 N,N-디메틸포름아미드 2.0ml를 사용하는것 외엔 실시예 4의 방법을 반복하여 3,4-디하이드로-2-메틸-4-옥소-2H-1,2-벤조티아진-3-카복실산-1,1-디옥사이에드의 산클로라이드를 제조한다.510 mg of 3,4-dihydro-2-methyl-4-oxo-2H-1,2-benzothiazine-3-carboxylic acid-1,1-dioxide, 1.45 ml of thionyl chloride, 10.0 ml of isopropyl ether, and N The procedure of Example 4 was repeated except that 2.0 ml of N-dimethylformamide was used. 3,4-dihydro-2-methyl-4-oxo-2H-1,2-benzothiazine-3-carboxylic acid-1 Prepare acid chlorides of 1, dioxide.

산클로라이드를 실시예 4의 아실화법에 따라 2-아미노티아졸(400mg)과 반응시켜 표제 생성물 532mg(79%, 조(組))을 얻는다.The acid chloride was reacted with 2-aminothiazole (400 mg) according to the acylation method of Example 4 to give 532 mg (79%, crude) of the title product.

이것을 60℃에서 N,N-디메틸아세트아미드에 용해시키고 용액을 여과한 후 여액을 메타놀(15ml)로 희석하여 정제한다. 수득량=208mg(33%) 융점 234-240℃It is dissolved in N, N-dimethylacetamide at 60 ° C., the solution is filtered and the filtrate is purified by dilution with methanol (15 ml). Yield = 208 mg (33%) Melting Point 234-240 ° C

이런처리를 반복하여 순수한 생성물을 얻는다.This treatment is repeated to obtain pure product.

생성물은 적외선 및 질량 분광분석법으로 확인한다.The product is confirmed by infrared and mass spectrometry.

[실시예 6]Example 6

N-(2-피리딜)-3,4-디하이드로-2-메틸-4-옥소-2H-1,2-벤조티아진-3-카복사미드-1,1-디옥사이드N- (2-pyridyl) -3,4-dihydro-2-methyl-4-oxo-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide

3,4-디하이드로-2-메틸-4-옥소-2H-1,2-벤조티아진-3-카복실산-1,1-디옥사이드(127mg)와 2-아미노피리딘(52mg)을 테트라하이드로푸란(5ml)에 녹인 용액에 교반하면서 N-에톡시카보닐-2-에톡시-1,2-디하이드로퀴놀린(148mg)을 테트라하이드로푸란(1ml)에 녹인 용액을 첨가한다. 혼합물을 실온(23-25℃)에서 4시간 동안 교반한 후 감압하에 농축시켜 오일로 한다.3,4-dihydro-2-methyl-4-oxo-2H-1,2-benzothiazine-3-carboxylic acid-1,1-dioxide (127 mg) and 2-aminopyridine (52 mg) were treated with tetrahydrofuran ( 5 ml) is added to a solution of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (148 mg) in tetrahydrofuran (1 ml) while stirring. The mixture is stirred at room temperature (23-25 ° C.) for 4 hours and then concentrated under reduced pressure to an oil.

벤젠 : 초산(95 : 5) 용매계에서 실리카겔상 박층 크로마토그라피하고 366mμ 램프하에서 판을 진짜 샘플과 비교하였을 때 표제 생성물이 존재했다.The title product was present when thin layer chromatography on silica gel in benzene: acetic acid (95: 5) solvent system and the plates were compared to the real samples under a 366 μm lamp.

N-에톡시카보닐-2-에톡시-1,2-디하이드로 퀴놀린 대신 커플링 시약으로 N,N'-디사이클로헥실카보디미드, N,N'-카보닐-S-트리아진, N,N-카보닐, 디-이미다졸, 에톡시아세틸렌, 디페닐케텐 P-톨릴아민, N-하이드록시석시니미드, N-하이드록시프탈리미드 또는 N-하이드록시피페리딘을 사용하여 상기 방법을 반복해도 유사한 결과가 얻어진다.N, N'-dicyclohexylcarbodimid, N, N'-carbonyl-S-triazine, N as coupling reagent instead of N-ethoxycarbonyl-2-ethoxy-1,2-dihydro quinoline Using N-carbonyl, di-imidazole, ethoxyacetylene, diphenylketene P-tolylamine, N-hydroxysuccinimide, N-hydroxyphthalimide or N-hydroxypiperidine Similar results are obtained by repeating the method.

Claims (1)

동몰량 이상의 일반식 R2NH2의 아민과 일반식(II)의 화합물을 커플링 시키는 것을 특징으로 하는 일반식(I)의 화합물을 제조 방법.A method for producing a compound of formula (I), comprising coupling an amine of the general formula R 2 NH 2 or more with an equivalent molar amount to a compound of formula (II).
Figure kpo00005
Figure kpo00005
위식에서In the common sense R2는 2-피리딜 또는 2-티아조릴기이고R 2 is a 2-pyridyl or 2-thiazolyl group Z는 상응하는 한 반응물의 활성 받는 유도체이며, 바람직하기로는 염소, 브롬 또는 OX(X는 수소, 1내지 4개의 탄소원자를 가지는 알콕시카르보닐옥시 및 벤질옥시카르보닐옥시기로부터 선택됨)이다.Z is the active receiving derivative of the corresponding reactant, preferably chlorine, bromine or OX (X is selected from alkoxycarbonyloxy and benzyloxycarbonyloxy groups having 1 to 4 carbon atoms).
KR7902985A 1976-06-10 1979-08-31 Process for preparing of 3,4-dihydro-2-methyl-4-oxo-2h-1,2-benzothiazine-3-carboxylic acid-1,1-dioxide KR810000291B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR7902985A KR810000291B1 (en) 1976-06-10 1979-08-31 Process for preparing of 3,4-dihydro-2-methyl-4-oxo-2h-1,2-benzothiazine-3-carboxylic acid-1,1-dioxide

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US694.572 1976-06-10
KR7902985A KR810000291B1 (en) 1976-06-10 1979-08-31 Process for preparing of 3,4-dihydro-2-methyl-4-oxo-2h-1,2-benzothiazine-3-carboxylic acid-1,1-dioxide

Publications (1)

Publication Number Publication Date
KR810000291B1 true KR810000291B1 (en) 1981-03-30

Family

ID=19212768

Family Applications (1)

Application Number Title Priority Date Filing Date
KR7902985A KR810000291B1 (en) 1976-06-10 1979-08-31 Process for preparing of 3,4-dihydro-2-methyl-4-oxo-2h-1,2-benzothiazine-3-carboxylic acid-1,1-dioxide

Country Status (1)

Country Link
KR (1) KR810000291B1 (en)

Similar Documents

Publication Publication Date Title
RU1836373C (en) Method for obtaining methyl ether of alpha -(4,5,6,7- tetrahydrothieno)(3,2-c) pyridyl-5- (2-chloro) -phenylacetic acid
JPS5834474B2 (en) Method for producing thiazolidine derivatives
JP2001518459A (en) Methods and intermediates useful for making antifolates
US4100347A (en) 3,4-Dihydro-2-methyl-4-oxo-2H-1,2-benzothiazine-3-carboxylic acid-1,1-dioxide
CS228520B2 (en) Method for the production of 4-hydroxy-2-methyl-n-2-pyridyl-2h-1,2-benzothiazin-3-carboxamid-1,1-dioxide
Hurd et al. Hydroxamic acids and N-hydroxyimides related to pyridine, pyrazine, and quinoxaline
KR810000291B1 (en) Process for preparing of 3,4-dihydro-2-methyl-4-oxo-2h-1,2-benzothiazine-3-carboxylic acid-1,1-dioxide
NO166712B (en) PROCEDURE FOR THE PREPARATION OF PYRROLIDO DERIVATIVES.
KR810000290B1 (en) Process for preparing of 3,4-dihydro-2-methyl-4-oxo-2h-1,2-benzothiazine-3-carboxylic acid-1,1-dioxide
US4042600A (en) Pyrolysis of 2-sulfochloride benzoates
SK285522B6 (en) Method for producing 4-(heteroarylmethyl)-halogen-1(2H)- phthalazinones
US4628083A (en) 2-hydroxy-5-(arylazo)-benzene alkanoic acids
US3725422A (en) New organic sulfur compounds and methods for their production
RU2228929C2 (en) Method for preparing (3s)-3-amino-3-pyridylpropionic acid and intermediate substance
US4837317A (en) Process for the preparation of 6-[D(-)alpha-(4-ethyl-2,3-dioxopiperazin-1-ylcarbonylamino)-alpha-phenylacetamido]-penicillanic acid and intermediates useful in this process
EP0236754B1 (en) Novel process for preparing 4-acetyl isoquinolinone compounds
US4259499A (en) Method for preparing 2-sulfochloride benzoates and the use of same in the preparation of saccharin
SU576046A3 (en) Method of preparing penicillin derivatives or salts thereof
CA1134366A (en) Salicylamide esters having therapeutical activity, process for their preparation and related pharmaceutical compositions
KR100503267B1 (en) Method for the preparation of 2-acetyloxy-4-trifluoromethyl benzoic acid
JPS6338354B2 (en)
SU429062A1 (en) A method for producing pyrido [2,3-b] [1,5] tiazepinones A method is proposed for producing pyrido [2,3-th] [! 1,5] thiazepiones that can be used as biologically active substances. derivatives of said heterocyclic system. Only derivatives of pyrimido [i2,5- &] ['1,5] thiazepinone are known, the preparation of which is based on the reaction of 5-amino-6-mercaptopyrimidines with p-bromopropionic acid chloride, followed by cyclization of the 5- (p-bromopropionyl) amino-6-mercaptopyrimidines and pyrimidothiazepines. It turned out that pyridothiazepinones could not be obtained by this method, since the reaction of 2-mercapto-3-aminopyridines with p-bromo-ropionic acid chloride proceeded simultaneously to the production of 4-bromine | resulting in the formation of compounds from which It is not possible to switch to pyridothiazepinones. A method is proposed for obtaining irido [2,3-6] [1,5] thiazepinones of the general formula 1Ri,, I ^ ', N— <where R is hydrogen, alkoxyl or halo; RI is hydrogen or alkyl. The method consists in that 2-mercapto-3-aminopyridine of the general formula 2IN'H, SH1015, where R has the indicated values, reacts with p-halogenoalkanoic acid in an environment of a solvent, for example an alcohol, in the presence of alkali metal hydroxides, thus obtained 2- (| p-Carboxyethyl) thio-3-aminopyridine of the general formula 320 and f ^^^^ - I II g - COOH-s - ^ 2530 The resulting compounds of Formula 1, where Ri is hydrogen, are either isolated by conventional administration or, if necessary, further converted into the desired compounds of general formula 1, wherein Ri • - alkyl, haloalkyl action, e.g.
CA1157850A (en) PROCESS FOR THE PREPARATION OF .beta.-LACTAM ANTIBIOTICS
EP0820999A1 (en) A process for the preparation of penicillins
JPS634546B2 (en)